HL-1186 Tablet for postoperative pain after orthopedic surgery
Official title: A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
Run by Shanghai Huilun Pharmaceutical Co., Ltd. · NCT07699601 · Data updated 2026-11-12
A mid-to-late phase trial tests HL-1186 tablets against placebo and standard opioid therapy to see if they can help manage pain after orthopedic surgery for adults 18–75.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 330 (estimated) |
| Sponsor | Shanghai Huilun Pharmaceutical Co., Ltd. Industry-sponsored |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | May 9, 2026 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT07699601 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 years old undergoing orthopedic surgery with expected moderate-to-severe postoperative pain and ability to consent and use pain scales.
✕Probably not a fit
Patients whose pain is not responsive to HL-1186 or who cannot tolerate the study medication may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized, double-blind study that compares HL-1186 tablets with placebo and with oxycodone-acetaminophen for postoperative analgesia following orthopedic procedures. It includes Phase II and Phase III components to assess safety and efficacy in adults with moderate-to-severe pain after surgery. Participants are adults aged 18 to 75 with BMI between 18 and 30 kg/m2, undergoing surgery under general anesthesia, and with a resting pain score of at least 4 after surgery. The trial uses parallel groups and standardized pain scales to evaluate outcomes, with nine potential arms including HL-1186, placebo, and active comparator.
Why it matters
Potential benefit: If successful, HL-1186 could provide effective pain relief with a favorable safety profile after orthopedic surgery.
How similar studies have gone: Previous studies with similar analgesic approaches in perioperative settings have shown potential benefits, but this specific HL-1186 program is novel in design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years old ≤ age ≤ 75 years old, gender is not limited. 2. 18 kg/m2 ≤ Body Mass Index (BMI) ≤ 30kg/m2. 3. Scheduled to undergo orthopedic surgery under general anesthesia, with expected moderate-to-severe postoperative pain intensity. 4. Able to understand the research process and the use of pain scales, and communicate effectively with researchers. 5. After surgery completion, the participant is judged by the investigator to be awake and has a resting NRS score ≥ 4. Exclusion Criteria: 1. Previous surgery on the same site that may affect pain perception at the surgical site. 2. Paresthesia or other pain that may affect postoperative pain evaluation or scale assessment. 3. Neuropsychological disorders that may affect postoperative pain evaluation or scale assessment. 4. Unstable angina, myocardial infarction, severe arrhythmia, NYHA cardiac function class ≥ III, or recurrent asthma attacks, etc., deemed unsuitable for inclusion by the investigator. 5. Poorly controlled hypertension. 6. Sleep apnea syndrome, or the presence of a difficult airway as assessed by the investigator. 7. Known allergy to any component of the investigational drug(s), to perioperative (from induction of anesthesia to completion of surgery) anesthetic/analgesic/antiemetic drugs, or a history of allergy to ≥ 3 substances. 8. Positive for human immunodeficiency virus (HIV) antibody; positive for Treponema pallidum antibody and positive toluidine red unheated serum test (TRUST); positive for hepatitis B surface antigen (HBsAg) with detectable HBV-DNA; or positive for hepatitis C virus (HCV) antibody. 9. Women who are pregnant or breastfeeding (within 1 year after delivery). 10. Participation in another drug or medical device trial within 1 month before screening, or currently participating in another clinical trial receiving investigational intervention. 11. Any other condition considered unsuitable for participation by the investigator.
Where it's running
-
The Third Xiangya Hospital of Central South University, Changsha, Hunan
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: MeiXuan Li
- Email: clinical_trial@hllife.com.cn
- Phone: 021-64311017
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Natural Biopolymer-Based Irrigant for Root Canal Cleaning
This trial tests a chitosan nanoparticle irrigant to improve cleaning and disinfection in single-rooted teeth with asymptomatic pulp necrosis undergoing endodontic treatment.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.